Findings lay the foundation for more personalized treatments
Findings to be presented during 2018 Annual Meeting of the American Urological Association
Testosterone-related genetic abnormality can help predict patient responses to prostate cancer therapies
National MENtion It campaign illustrates how important it is to know your family health history
Study in journal Cell Chemical Biology highlights need for new treatment approaches
IsoPSA assay can help in determining the need for prostate biopsy for patients
Nima Sharifi, M.D., honored by Clinical Research Forum for research showing that testosterone-related genetic mutation leads to deadlier outcomes in prostate cancer